Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

C14orf54 Activators

C14orf54 Activators encompass a diverse group of chemical compounds that, while not directly interacting with C14orf54, facilitate its functional activity within its associated signaling pathways. Forskolin, by increasing cAMP, and IBMX, through inhibiting phosphodiesterases, both raise the levels of cyclic nucleotides, leading to the activation of PKA and other cAMP/cGMP-dependent kinases; this can indirectly result in the phosphorylation of C14orf54 or its partners, enhancing its signaling capacity. Similarly, PMA stimulates PKC, potentially phosphorylating C14orf54-related proteins and amplifying its activity in PKC-dependent pathways. Ionomycin and A23187, both acting as calcium ionophores, elevate intracellular calcium levels, which may activate calcium-dependent kinases that target C14orf54 for activation. Calyculin A and Okadaic acid, as phosphatase inhibitors, prevent the dephosphorylation of proteins within the C14orf54 pathway, possibly maintaining C14orf54 in an active state.

Further supporting the activity of C14orf54, Anisomycin, through the induction of stress-activated protein kinases, could lead to the activation of C14orf54 in response to cellular stress or apoptotic signals. The cAMPand cGMP analogs, 8-Br-cAMP and 8-Br-cGMP, mimic the effects of the endogenous cyclic nucleotides, potentially activating PKA or PKG, respectively, and thus promoting the activation of C14orf54 through these kinase pathways. Thapsigargin, by inhibiting the SERCA pump, causes an increase in cytosolic calcium, which can subsequently activate calcium-dependent signaling cascades that involve C14orf54. Finally, Staurosporine, despite being a broad-spectrum kinase inhibitor, may paradoxically enhance the functional activity of C14orf54 by inhibiting kinases that normally suppress C14orf54's signaling pathways, thereby allowing for an increase in the protein's functional activity. Collectively, these activators work through distinct but interconnected biochemical mechanisms to enhance the activity of C14orf54, ensuring the protein's participation in the proper functioning of its associated cellular signaling networks.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, which increases intracellular cAMP and cGMP levels. Elevated cAMP/cGMP can enhance C14orf54 activity by stimulating signaling pathways that depend on these cyclic nucleotides.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which can lead to the phosphorylation of substrates that may include C14orf54 or its associated proteins, thereby enhancing its function within its signaling pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases that may phosphorylate and activate C14orf54 or its related proteins.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. This could result in enhanced activity of C14orf54 by preventing dephosphorylation of proteins in pathways where C14orf54 is involved.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic acid is another inhibitor of protein phosphatases 1 and 2A, which may increase the phosphorylation state of proteins in the C14orf54 pathway, potentially enhancing its activity.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs/JNKs), possibly leading to the activation of C14orf54 within the context of stress response or apoptosis signaling pathways.

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$108.00
$169.00
$295.00
$561.00
$835.00
2
(1)

8-Br-cAMP is a cAMP analog that activates cAMP-dependent pathways, potentially leading to the activation of C14orf54 through phosphorylation events mediated by PKA.

8-Bromo-cGMP

51116-01-9sc-200316
sc-200316A
10 mg
50 mg
$104.00
$354.00
7
(1)

8-Br-cGMP is a cGMP analog that activates cGMP-dependent pathways, potentially leading to the activation of C14orf54 through phosphorylation events mediated by PKG.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium, which may activate calcium-dependent proteins and pathways, potentially enhancing the function of C14orf54.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is a calcium ionophore that increases intracellular calcium concentration, potentially activating C14orf54 by promoting the activity of calcium-dependent signaling pathways.